Lighting It Up With Acuity
Given the premium paid in the Genlyte deal, Acuity looks extremely undervalued.
And the sun shines on the bay
I want to be there in my city
- Lights (Journey)
O.K., laugh all you want, but I have always been a bit of a Journey fan.
Granted, these guys are the stereotypical 80's band right down to the acrimonious break up, but I still find myself turning up the radio every time a Journey tune comes on. Lights was written about San Francisco and is one of those songs you cannot help but sing along to. My favorite lyric from the song? "So you think you're lonely, Well my friend I'm lonely too" - just fantastic.
Well, up until the other day, Genlyte (GLYT) was a very lonely stock.
After topping out around $87.75 in June, Genlyte saw its stock price plummet down to $57.15 in late October. The hysteria that gripped the housing market quickly spread to the downstream industries and the market took no prisoners.
Then seemingly out of nowhere on November 26, Philips (PHG) comes along and announces it is going to acquire Genlyte for $95.50/share, or $2.7 bln cash.
Well, with all bad news in the housing market and recently the non-residential construction market one would think that Philips could have acquired GLYT "on the cheap." A 10% premium perhaps, maybe 15%, worst case 25%? None of the above folks. Phillips paid just north of a 50% premium from the close of the prior trading session.
According to its website, "The Genlyte Group Incorporated is a leading manufacturer of lighting fixtures, controls, and related products for the commercial, industrial and residential markets." If we take for granted the fact that Philips did its proper due diligence in terms of examining Genlyte, we are left with one conclusion. Phillips is making a rather large statement about its views going forward on the health of the construction market, be it residential or non-residential.
The Genlyte trade is over. But there may be another one that still has yet to hit the radar screen of Wall Street. Acuity Brands (AYI) is another one of the world's leading providers of lighting fixtures. Whether or not AYI will become a takeover candidate remains to be seen. But one thing that seems certain is that, given the premium paid in the Genlyte deal, Acuity looks extremely undervalued. After topping out around $66 in July, Acuity, much like Genlyte, saw its stock price crushed, trading down to $34.04 earlier this month.
At around 12 times trailing and 9.5 times forward earnings, Acuity is significantly cheaper than Genlyte's current valuations of 19 times trailing and 17 times forward earnings. On top of that, with a relatively small float of 42 mln shares and a 12% short interest, AYI is one of those stocks that the shorts love on the way down, but break out into a cold sweat from on the way up. On October 4, AYI reported a lackluster 4Q where its EPS of $1.18 was in-line but revenues of $693 mln fell short of "Street consensus" of $712.1 mln. But 2007 was a rather nice year, all in all, for Acuity. Net income increased 39% to $148 mln. Net sales grew 6% to over $2.5 bln and maybe most importantly, return on shareholders' equity rose to a record 24%.
The management team, led by Chairman of the Board, President and Chief Executive Officer Vernon Nagel, seem to be doing everything right. My sense is now that we have seen the Philips/Genlyte deal, Wall Street analysts are scrambling to get up to speed on other leading names in the space. Acuity is going to be one of the names that will start to get a lot of attention.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter